The effect of oral cyclosporine in the treatment of severe alopecia areata

Cutaneous and Ocular Toxicology

Volumn 33, Issue 3, 2014, Pages 247-252

  Açikgöz, Gürol ^a   Çalişkan, Ercan ^a   Tunca, Mustafa ^a   Yeniay, Yildiray ^a   Akar, Ahmet ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

Author keywords

Calcineurin inhibitors; Hair loss; Immunosuppressive drugs; Therapy

Indexed keywords

CYCLOSPORIN; LIVER ENZYME; MINOXIDIL; STEROID; IMMUNOSUPPRESSIVE AGENT;

ACUTE KIDNEY FAILURE; ADULT; ALOPECIA AREATA; ARTICLE; CLINICAL ARTICLE; DISEASE DURATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FAMILY HISTORY; HAIR GROWTH; HUMAN; HYPERTRANSAMINASEMIA; MALE; NORMAL HUMAN; PROGNOSIS; PUVA; STEROID THERAPY; TOPICAL TREATMENT; TREATMENT DURATION; TREATMENT RESPONSE; YOUNG ADULT; ALOPECIA; CLINICAL TRIAL; ORAL DRUG ADMINISTRATION; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ADULT; ALOPECIA; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84906707305     PISSN: 15569527     EISSN: 15569535     Source Type: Journal    
DOI: 10.3109/15569527.2013.839997     Document Type: Article

References (14)

1. Kim BJ, Min SU, Park KY, et al. Combination therapy of cyclosporine and methylprednisolone on severe alopecia areata. J Dermatolog Treat 2008;19:216-220.
2. Kurosawa M, Nakagawa S, Mizuashi M, et al. A comparison of the efficacy, relapse rate and side effects among three modalities of systemic corticosteroid therapy for alopecia areata. Dermatology 2006;212:361-365.
3. Madani S, Shapiro J. Alopecia areata update. J Am Acad Dermatol 2000;42:549-566; quiz 567-570.
4. Acikgoz G, Ozmen I, Cayirli M, et al. Pulse methylprednisolone therapy for the treatment of extensive alopecia areata. J Dermatolog Treat 2013. [Epub ahead of print]. doi: 10.3109/ 09546634.2013.768759.
5. Flechner SM. Cyclosporine: a new and promising immunosuppressive agent. Urol Clin North Am 1983;10:263-275.
6. Gupta AK, Ellis CN, Cooper KD, et al. Oral cyclosporine for the treatment of alopecia areata. A clinical and immunohistochemical analysis. J Am Acad Dermatol 1990; 22:242-250.
7. Moreno JC, Ocana MS, Velez A. Cyclosporin A and alopecia areata. J Eur Acad Dermatol Venereol 2002;16:417-418.
8. Teshima H, Kihara H, Nakagawa T, Hori Y. Effective therapy with low dose of oral cyclosporine A and prednisolone for alopecia universalis. Arerugi 1990;39:714-717.
9. Teshima H, Urabe A, Irie M, et al. Alopecia universalis treated with oral cyclosporine A and prednisolone: immunologic studies. Int J Dermatol 1992;31:513-516.
10. Shaheedi-Dadras M, Karami A, Mollaei F, et al. The effect of methylprednisolone pulse-therapy plus oral cyclosporine in the treatment of alopecia totalis and universalis. Arch Iran Med 2008; 11:90-93.
11. Rallis E, Nasiopoulou A, Kouskoukis C, et al. Oral administration of cyclosporin A in patients with severe alopecia areata. Int J Tissue React 2005;27:107-110.
12. Shapiro J, Lui H, Tron V, Ho V. Systemic cyclosporine and low-dose prednisone in the treatment of chronic severe alopecia areata: a clinical and immunopathologic evaluation. J Am Acad Dermatol 1997;36:114-117.
13. Özcan A, Şenol M, Şener S, et al. Low dose cyclosporine and prednisolone combination in the treatment of diffuse alopecia areata and alopecia universalis. Turkiye Klinikleri J Dermatol 2001;11:16-20.
14. Phillips MA, Graves JE, Nunley JR. Alopecia areata presenting in 2 kidney-pancreas transplant recipients taking cyclosporine. J Am Acad Dermatol 2005;53:S252-S255.